Trial
NCT02449681
Study for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Rain Oncology Inc
Collaborators
—
Condition
Metastatic Head-and-neck Squamous-cell Carcinoma
Intervention
TH-4000 (Tarloxotinib)
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-12